| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |